These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 36222052)
1. Integrative analysis of a novel 5 methylated snoRNA genes prognostic signature in patients with glioma. Yue X; Zheng Y; Li L; Yang Z; Chen Z; Wang Y; Wang Z; Zhang D; Bian E; Zhao B Epigenomics; 2022 Sep; 14(18):1089-1104. PubMed ID: 36222052 [No Abstract] [Full Text] [Related]
2. A prognostic signature based on snoRNA predicts the overall survival of lower-grade glioma patients. Zhou Y; Yin W; Kuang Y; Wu Z; Huang H; Liu W; Jiang X; Ren C Front Immunol; 2023; 14():1138363. PubMed ID: 38022536 [TBL] [Abstract][Full Text] [Related]
3. Identification of a mesenchymal-related signature associated with clinical prognosis in glioma. Zhang Z; Chen J; Huo X; Zong G; Huang K; Cheng M; Sun L; Yue X; Bian E; Zhao B Aging (Albany NY); 2021 Apr; 13(9):12431-12455. PubMed ID: 33875619 [TBL] [Abstract][Full Text] [Related]
4. A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma. Cheng M; Sun L; Huang K; Yue X; Chen J; Zhang Z; Zhao B; Bian E Front Oncol; 2021; 11():646409. PubMed ID: 33828990 [TBL] [Abstract][Full Text] [Related]
5. Identification of potential prognostic small nucleolar RNA biomarkers for predicting overall survival in patients with sarcoma. Liu J; Liao X; Zhu X; Lv P; Li R Cancer Med; 2020 Oct; 9(19):7018-7033. PubMed ID: 32780509 [TBL] [Abstract][Full Text] [Related]
6. Integrative Analysis of a Novel Eleven-Small Nucleolar RNA Prognostic Signature in Patients With Lower Grade Glioma. Deng T; Gong Y; Liao X; Wang X; Zhou X; Zhu G; Mo L Front Oncol; 2021; 11():650828. PubMed ID: 34164339 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma. Zeng F; Wang K; Liu X; Zhao Z Cell Commun Signal; 2020 Jan; 18(1):2. PubMed ID: 31907037 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatic Profiling Identifies a Glucose-Related Risk Signature for the Malignancy of Glioma and the Survival of Patients. Zhao S; Cai J; Li J; Bao G; Li D; Li Y; Zhai X; Jiang C; Fan L Mol Neurobiol; 2017 Dec; 54(10):8203-8210. PubMed ID: 27900679 [TBL] [Abstract][Full Text] [Related]
9. Expression scoring of a small-nucleolar-RNA signature identified by machine learning serves as a prognostic predictor for head and neck cancer. Xing L; Zhang X; Zhang X; Tong D J Cell Physiol; 2020 Nov; 235(11):8071-8084. PubMed ID: 31943178 [TBL] [Abstract][Full Text] [Related]
10. Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes. Hu Z; Zhang H; Fan F; Wang Z; Xu J; Huang Y; Dai Z; Cao H; Zhang X; Liu Z; Cheng Q Front Immunol; 2021; 12():737650. PubMed ID: 34804019 [TBL] [Abstract][Full Text] [Related]
11. Amino acid metabolism-related gene expression-based risk signature can better predict overall survival for glioma. Liu YQ; Chai RC; Wang YZ; Wang Z; Liu X; Wu F; Jiang T Cancer Sci; 2019 Jan; 110(1):321-333. PubMed ID: 30431206 [TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic value of mRNAs in lower grade glioma with MGMT promoter methylated. Wang W; Li J; Lin F; Guo J; Zhao J J Clin Neurosci; 2020 May; 75():45-51. PubMed ID: 32229069 [TBL] [Abstract][Full Text] [Related]
13. Genome-wide small noncoding RNA profiling of pediatric high-grade gliomas reveals deregulation of several miRNAs, identifies downregulation of snoRNA cluster HBII-52 and delineates H3F3A and TP53 mutant-specific miRNAs and snoRNAs. Jha P; Agrawal R; Pathak P; Kumar A; Purkait S; Mallik S; Suri V; Chand Sharma M; Gupta D; Suri A; Sharma BS; Julka PK; Kulshreshtha R; Sarkar C Int J Cancer; 2015 Nov; 137(10):2343-53. PubMed ID: 25994230 [TBL] [Abstract][Full Text] [Related]
14. A Novel Risk Signature with Seven Pyroptosis-Related Genes for Prognosis Prediction in Glioma. Huang Q; Li J; Mo L; Zhao Y World Neurosurg; 2022 Mar; 159():e285-e302. PubMed ID: 34929369 [TBL] [Abstract][Full Text] [Related]
15. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma. Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773 [TBL] [Abstract][Full Text] [Related]
16. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma. Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling. Bao ZS; Li MY; Wang JY; Zhang CB; Wang HJ; Yan W; Liu YW; Zhang W; Chen L; Jiang T CNS Neurosci Ther; 2014 Feb; 20(2):112-8. PubMed ID: 24279471 [TBL] [Abstract][Full Text] [Related]
18. Expression signature of six-snoRNA serves as novel non-invasive biomarker for diagnosis and prognosis prediction of renal clear cell carcinoma. Zhao Y; Yan Y; Ma R; Lv X; Zhang L; Wang J; Zhu W; Zhao L; Jiang L; Zhao L; Wen L; Yang B; Chen Y; He M; Liu M; Wei M J Cell Mol Med; 2020 Feb; 24(3):2215-2228. PubMed ID: 31943775 [TBL] [Abstract][Full Text] [Related]
19. Transcriptomic Profiling Identifies a DNA Repair-Related Signature as a Novel Prognostic Marker in Lower Grade Gliomas. Zeng F; Liu X; Wang K; Zhao Z; Li G Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2079-2086. PubMed ID: 31533943 [TBL] [Abstract][Full Text] [Related]
20. N6-methyladenine-related genes affect biological behavior and the prognosis of glioma. Qu S; Chen Z; Liu B; Liu J; Wang H Cancer Med; 2021 Jan; 10(1):98-108. PubMed ID: 33264518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]